Your browser doesn't support javascript.
loading
Levofloxacin exerts broad-spectrum anticancer activity via regulation of THBS1, LAPTM5, SRD5A3, MFAP5 and P4HA1.
He, Xiaoqiong; Yao, Qian; Hall, Duane D; Song, Zhongyu; Fan, Dan; You, Yutong; Lian, Wenjing; Zhou, Zhangping; Duan, Ling; Chen, Biyi.
Affiliation
  • He X; Department of Food Science and Nutrition, School of Public Health, Kunming Medical University.
  • Yao Q; Department of Cellular Biology, Institute of Yunnan Tumor, the Third Affiliated Hospital of Kunming Medical University, Kunming, Yunnan Province, People's Republic of China.
  • Hall DD; Department of Medicine, Carver College of Medicine, The University of Iowa, Iowa City, Iowa, USA.
  • Song Z; Department of Cellular Biology, Institute of Yunnan Tumor, the Third Affiliated Hospital of Kunming Medical University, Kunming, Yunnan Province, People's Republic of China.
  • Fan D; Department of Food Science and Nutrition, School of Public Health, Kunming Medical University.
  • You Y; Department of Food Science and Nutrition, School of Public Health, Kunming Medical University.
  • Lian W; Department of Food Science and Nutrition, School of Public Health, Kunming Medical University.
  • Zhou Z; Department of Food Science and Nutrition, School of Public Health, Kunming Medical University.
  • Duan L; Department of Food Science and Nutrition, School of Public Health, Kunming Medical University.
  • Chen B; Department of Medicine, Carver College of Medicine, The University of Iowa, Iowa City, Iowa, USA.
Anticancer Drugs ; 33(1): e235-e246, 2022 01 01.
Article in En | MEDLINE | ID: mdl-34419964

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gene Expression Regulation, Neoplastic / Levofloxacin Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Anticancer Drugs Journal subject: ANTINEOPLASICOS Year: 2022 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gene Expression Regulation, Neoplastic / Levofloxacin Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Anticancer Drugs Journal subject: ANTINEOPLASICOS Year: 2022 Type: Article